Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Leuprorelin acetate + Sintilimab
The First People's Hospital of Lianyungang
NSCLC, Stage III
1 trial -
Levetiracetam (Keppra)
United Therapeutics Europe Ltd
Alcohol Abuse
1 trial -
Lung Ultrasound (LUS)
Grace Therapeutics
Community-acquired Pneumonia
1 trial -
MINGO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
X-Linked Dystonia Parkinsonism
1 trial -
Mailed nicotine replacement therapy (NRT)
The University of Hong Kong
Smoking Cessation
1 trial -
Megestrol acetate
ACTUATE THERAPEUTICS, INC.
HIV Infections
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Minocycline
The First People's Hospital of Lianyungang
Intracerebral Hemorrhage
1 trial -
Misoprostol 25 µg Vaginal
ANI PHARMACEUTICALS INC
Cervical Ripening
1 trial -
Naglazyme®
BioMarin Pharmaceutical Australia Pty Ltd
Maroteaux-Lamy Syndrome
1 trial -
Neomycin/ Dexameythasone/Xylometazoline
Biotech Pharmaceutical Co.,
Rhinosinusitis
1 trial -
Neutral environment with radiation
Petros Pharmaceuticals
Heat Stress
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nicotine Replacement Therapy (Habitrol)
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotine Replacement Treatment (NRT)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Nicotine Replacement therapy
The University of Hong Kong
Smoking
1 trial -
Nicotine replacement therapy sampling
United Therapeutics Europe Ltd
Smoking Cessation
1 trial -
Normal Saline (Placebo)
The First People's Hospital of Lianyungang
Disease of Respiratory System
1 trial -
Oligo Fucoidan
Biotech Pharmaceutical Co.,
NSCLC Stage IV
1 trial -
Olive oil
Universe Pharmaceuticals INC
Severe Obesity
1 trial -
On-site radiologist
International Peace Maternity and Child Health Hospital
Tuberculosis
1 trial -
Open Placebo
BRIGHT MINDS BIOSCIENCES INC.
Acute Pain
1 trial -
Oral Chondroitin Sulfate (Flextrum)
COLLEGIUM PHARMACEUTICAL, INC
Meniscus Lesion
1 trial -
PROGRAM
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Obesity
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources